Skip to content
CINGCingulate Inc.

Earnings

When Cingulate Inc. reports, what it reported each quarter, and how the stock took the results.

23 quarters. Mar 31, 2021 to Sep 30, 2026. mixed units.

Next results · Q4 2026Projected

Mar 17, before the open

Wed, Mar 17, 2027in 120 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 8 – Apr 5

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Net income
-$6.27M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026-$7.73MNo Q3 2025 on file

Latest results

  1. Q3 2026Nov 13, 2026, after the closeThe release
    Revenue
    —
    —
    Net income
    -$7.73M
    N/M
    EPS
    -$0.53
    N/M
    Cingulate Inc. Reports Third Quarter 2026 Financial Results and Provides Regulatory Update on CTx-1301 NDA Resubmission
  2. Q2 2026Aug 13, 2026, before the openThe release4.2%by the close of Aug 13
    Revenue
    —
    —
    Net income
    -$5.87M
    N/M
    EPS
    -$0.45
    N/M
  3. Q1 2026May 14, 2026, before the openThe release10.4%by the close of May 14
    Revenue
    —
    —
    Net income
    -$9.31M
    N/M
    EPS
    -$0.95
    N/M
  4. Q4 2025Mar 18, 2026, before the openThe release31.4%by the close of Mar 18
    Revenue
    —
    —
    Net income
    -$6.27M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 13, 2026 · after-hoursNov 13, 202644 d10-Q——-$0.53—
Q2 2026Jun 30, 2026Aug 13, 2026 · pre-marketAug 13, 202644 d10-Q——-$0.454.2%
Q1 2026Mar 31, 2026May 14, 2026 · pre-marketMay 14, 202644 d10-Q——-$0.9510.4%
FY 2025
Q4 2025derivedDec 31, 2025Mar 18, 2026 · pre-marketMar 18, 202677 d10-K———31.4%
Q3 2025Sep 30, 2025Nov 13, 2025 · pre-marketNov 13, 202544 d10-Q——-$1.3511.0%
Q2 2025Jun 30, 2025Aug 19, 2025 · pre-marketAug 19, 202550 d10-Q——-$1.149.6%
Q1 2025Mar 31, 2025May 8, 2025 · after-hoursMay 8, 202538 d10-Q——-$1.061.5%
FY 2024
Q4 2024derivedDec 31, 2024Mar 26, 2025 · pre-marketMar 27, 202586 d10-K———+3.0%
Q3 2024Sep 30, 2024Nov 7, 2024 · pre-marketNov 7, 202438 d10-Q——-$2.34+2.1%
Q2 2024Jun 30, 2024Aug 13, 2024 · pre-marketAug 13, 202444 d10-Q——-$5.4721.3%
Q1 2024Mar 31, 2024May 8, 2024 · pre-marketMay 8, 202438 d10-Q——-$7.21+2.3%
Earlier years, FY 2021 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 13, 2026051851
10-QAug 13, 2026037606
10-QMay 14, 2026022884
10-KMar 18, 2026010882
10-QNov 13, 2025022395
10-QAug 19, 2025024744
10-QMay 8, 2025009289
10-KMar 27, 2025000970
10-QNov 7, 2024043916
10-QAug 13, 2024031469

Provenance

ProvenanceData status and checks

Cingulate Inc. · CIK 1862150 · Engraved from SEC EDGAR